AJP - Endocrinology and Metabolism, Vol 263, Issue 2 E181-E194, Copyright © 1992 by American Physiological Society

ARTICLES

Atrial natriuretic peptide-induced inhibition of aldosterone secretion: a quest for mediator(s)

A. Ganguly

Atrial natriuretic peptide (ANP) inhibits aldosterone secretion evoked by its physiological secretagogues by a mechanism(s) likely to involve intracellular messengers. When one examines the results of various investigations so far, this premise, although not definitive yet, seems to be supported. Therefore a brief perspective on the cellular messengers of the various secretagogues is provided before the inquiry into the possible mechanism of action of ANP. The receptors of ANP in the adrenal cells have been identified and characterized. ANP inhibits adenylate cyclase in various tissues through an inhibitory G protein, which appears to explain in part the inhibitory effect of ANP on adrenocorticotropin-induced aldosterone secretion. However, there could be other possible effects of ANP as discussed. ANP probably inhibits aldosterone secretion evoked by angiotensin II and potassium by interfering with the appropriate changes in calcium flux and cell calcium concentration, concomitants of stimulation by these secretagogues. The potential modes of these effects are probed. The role of guanosine 3',5'-cyclic monophosphate, which is increased by receptor activation of guanylate cyclase by ANP and is thought to play a major role in the biological effects of ANP in some other tissues, remains controversial in the aldosterone-lowering effect of ANP, and this is also discussed extensively in this review.

This article has been cited by other articles:

				D. Zhao, E. Vellaichamy, N. K. Somanna, and K. N. Pandey Guanylyl cyclase/natriuretic peptide receptor-A gene disruption causes increased adrenal angiotensin II and aldosterone levels Am J Physiol Renal Physiol, July 1, 2007; 293(1): F121 - F127. [Abstract] [Full Text] [PDF]

				A. SPAT and L. HUNYADY Control of Aldosterone Secretion: A Model for Convergence in Cellular Signaling Pathways Physiol Rev, April 1, 2004; 84(2): 489 - 539. [Abstract] [Full Text] [PDF]

				Y. Ogura, S. Matsuda, M. Ito, R. Niimi, M. Sumitomo, and Y. Kawarada Chemoprevention of biliary carcinogenesis in Syrian hamsters by the novel carboxamide derivative IS-741 after initiation with N-nitrosobis(2-oxopropyl)amine (BOP) Carcinogenesis, August 1, 2000; 21(8): 1469 - 1475. [Abstract] [Full Text] [PDF]

				L. G. Melo, A. T. Veress, C. K. Chong, S. C. Pang, T. G. Flynn, and H. Sonnenberg Salt-sensitive hypertension in ANP knockout mice: potential role of abnormal plasma renin activity Am J Physiol Regulatory Integrative Comp Physiol, January 1, 1998; 274(1): R255 - R261. [Abstract] [Full Text] [PDF]

				T. J. Tunny, R. D. Gordon, S. A. Klemm, and M. Stowasser Reduced Renal Extraction of Atrial Natriuretic Peptide in Primary Aldosteronism Hypertension, October 1, 1995; 26(4): 624 - 627. [Abstract] [Full Text]